Table 2.

Patient Characteristics

Characteristic	FU-Based Arm 1 (n = 28)		Non–FU-Based Arm 2 (n = 45)
	No.	%	No.	%
Age
Median	57		54
Range	44-81		34-71
Sex
Male	16	57	31	69
Female	12	43	14	31
Zubrod performance status
0	16	57	25	56
1	12	43	20	44
Type of surgery
Total gastrectomy	10	36	8	18
Distal subtotal gastrectomy	12	43	19	42
Proximal subtotal gastrectomy	6	21	18	40
Primary site
Cardia	5	18	12	27
Fundus	0		3	7
Body	1	4	0
Antrum	9	32	8	18
Pylorus	3	11	6	13
Lesser curvature	6	21	8	18
Greater curvature	0		2	4
Stomach, NOS	4	14	6	13
Depth of penetration
Submucosal	1	4	0
Lamina propria	0		1	2
Subserosa	5	18	9	20
Muscularis propria	8	29	17	38
Serosa	14	50	15	33
Spleen, transverse colon, diaphragm retroperitoneum	0		2	4
Other	0		1	2
T stage/pathologic
T1	1	4	1	2
T2	14	50	26	58
T3	12	43	17	38
T4	1	4	1	2
N stage/pathologic
N0	5	18	8	18
N1	18	64	26	58
N2	5	18	11	24
Stage group
IB	4	14	3	7
II	10	36	18	40
IIIA	12	43	22	49
IIIB	2	7	2	4

Abbreviations: FU, fluorouracil; NOS, not otherwise specified.